- NYSE: RCL is on the rise on the day that the US beings vaccinating its population against COVID-19.
- A return to normal would allow Royal Caribbean Cruises to bring elderly customers onboard.
- Investors are shrugging off the firm's financial woes.
A small clinic in Long Island, New York, administered the first coronavirus vaccine in the US and own in Miami Florida, management at Royal Caribbean Cruises (NYSE: RCL) is also cheering. The Pfizer/BioNTech jab will probably be joined by other immunizations in bringing the world's richest country to controlling the disease that has killed nearly 300,000 people.
Most of the cruise sector's clientele are elderly people that are more likely to develop serious COVID-19 illness and have a higher chance to pass away. Moreover, many of those opting for a sedentary vacation on the seas suffer from additional health issues, increasing their risk. If everything goes to plan, most of these high-risk individuals – which have priority – will be immune to covid within several months.
The grand effort has begun on Monday after the Food and Drugs Administration (FDA) approved the drug on Friday. The regulator will likely grant Moderna's authorization as early as the end of this week.
The upbeat news comes after a bruising year to cruising and Royal Caribbean in particular.
RCL stock forecast
NYSE: RCL is trading up by 0.79% on Monday, changing hands at $76.94, a far cry from the 52-week high of $135.32. Cruising ships were seen as floating contagion spaces after the Diamond Princess was moored at the Tokyo bay early in the year. More recently, a cruise ship that went for a sail out of Singapore had to halt its journey after a client became a covid patient.
Moreover, and contrary to rival Carnival, RCL has financial issues. Alongside Norweigan Cruise Line, another competitor, Royal was put on credit watch by S&P Global Ratings. The renowned credit rating firm cited extensions of cruising suspensions as the primary reason for the warning.
Overall, there is room for recovery, but the seas may be stormy until vaccines prompt enough clients to book a cruise.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD consolidates weekly gains above 1.1150
EUR/USD moves up and down in a narrow channel slightly above 1.1150 on Friday. In the absence of high-tier macroeconomic data releases, comments from central bank officials and the risk mood could drive the pair's action heading into the weekend.
GBP/USD stabilizes near 1.3300, looks to post strong weekly gains
GBP/USD trades modestly higher on the day near 1.3300, supported by the upbeat UK Retail Sales data for August. The pair remains on track to end the week, which featured Fed and BoE policy decisions, with strong gains.
Gold extends rally to new record-high above $2,610
Gold (XAU/USD) preserves its bullish momentum and trades at a new all-time high above $2,610 on Friday. Heightened expectations that global central banks will follow the Fed in easing policy and slashing rates lift XAU/USD.
Week ahead – SNB to cut again, RBA to stand pat, PCE inflation also on tap
SNB is expected to ease for third time; might cut by 50bps. RBA to hold rates but could turn less hawkish as CPI falls. After inaugural Fed cut, attention turns to PCE inflation.
Bank of Japan set to keep rates on hold after July’s hike shocked markets
The Bank of Japan is expected to keep its short-term interest rate target between 0.15% and 0.25% on Friday, following the conclusion of its two-day monetary policy review. The decision is set to be announced during the early Asian session.
Moneta Markets review 2024: All you need to know
VERIFIED In this review, the FXStreet team provides an independent and thorough analysis based on direct testing and real experiences with Moneta Markets – an excellent broker for novice to intermediate forex traders who want to broaden their knowledge base.